Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, et al
Through a variety of mechanisms, metabolic syndrome increases our risk for cardiovascular disease, which can manifest as both acute and chronic blockages in the arteries supplying blood to our heart, strokes, heart rhythm abnormalities, and heart failure (weakness and stiffness of the heart muscle). The GLP1 [weight loss] drugs are the best available medications for treatment of obesity
#AndrogenReplacementTherapy #TestosteroneTherapy #TRT #HealthcareInnovation #PharmaIndustry #FDA #RegulatoryUpdate #Biopharma #MarketGrowth #Pharmaceuticals #MenHealth #HealthcareTrends #DrugDevelopment #GlobalMarkets To view or add a comment, sign in Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in NEJM Evidence #ANAB #EV #Healthcare #Investing To view or add a comment, sign in Specialty pharma needs sharper U.S
Strength training and a high-protein diet are still your foundation.